CytomX Therapeutics (CTMX) FCF Margin Growth (5y) (2019 - 2026)
CytomX Therapeutics (CTMX) FCF Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,817.00 |
| Dec 31, 2025 | -331,445.00 |
| Sep 30, 2025 | 8,235.00 |
| Jun 30, 2025 | -147,358.00 |
| Mar 31, 2025 | 6,674.00 |
| Dec 31, 2024 | 31,209.00 |
| Sep 30, 2024 | 17,787.00 |
| Jun 30, 2024 | 44,580.00 |
| Mar 31, 2024 | 16,268.00 |
| Dec 31, 2023 | 15,558.00 |
| Sep 30, 2023 | -1,007.00 |
| Jun 30, 2023 | 16,932.00 |
| Mar 31, 2023 | 14,535.00 |
| Dec 31, 2022 | -9,265.00 |
| Sep 30, 2022 | -28,330.00 |
| Jun 30, 2022 | -223,664.00 |
| Mar 31, 2022 | -29,938.00 |
| Dec 31, 2021 | -30,367.00 |
| Sep 30, 2021 | 12,581.00 |
| Jun 30, 2021 | -83,695.00 |